UK Pharma Industry Seeks Tax Clarity On Clinically Justified Treatments
The pharmaceutical industry is seeking government confirmation regarding the tax status of clinically justified drug treatments and supplies. Industry representatives are urging the government to ensure these treatments remain free of charge for patients. The current tax situation is reportedly causing operational problems for the sector. The shadow science, innovation, and technology secretary noted that the situation may impact the United Kingdom's reputation. Discussions regarding the specific tax application are expected to continue on a case-by-case basis.
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Times Radio UK
“the pharma industry, understandably, is looking for further clarity, and it's urging the government to confirm that clinically justified treatments and supply of such drugs should be free of charge.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade